MINNEAPOLIS, May 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2025.Third Quarter FY2025 Highlights Third quarter organic revenue increased by 6% (4% reported) to $316.2 million. GAAP earnings per share (EPS) was$0.14 versus $0.31 one year ago. Delivered adjusted EPS of$0.56 compared to $0.48 one year ago. Improved pharma end market conditions, combined with strong commercial execution in Protein Sciences led to 7% ...